MEDINCELL (MEDCL) — key financial figures for fiscal year 2023 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

€11.9M

Net Income/Loss (FY2023)

-€25.0M

Total Assets (FY2023)

€36.9M

Total Equity (FY2023)

-€40.8M

Cash Flows from Operating Activities (FY2023)

-€11.9M

Source: MEDINCELL annual_report filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.